Compare · ALGN vs INGN
ALGN vs INGN
Side-by-side comparison of Align Technology Inc. (ALGN) and Inogen Inc (INGN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALGN and INGN operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ALGN is the larger of the two at $12.44B, about 71.5x INGN ($174.1M).
- Over the past year, ALGN is down 5.3% and INGN is down 3.5% - INGN leads by 1.9 points.
- INGN has been more active in the news (10 items in the past 4 weeks vs 3 for ALGN).
- ALGN has more recent analyst coverage (25 ratings vs 11 for INGN).
- Company
- Align Technology Inc.
- Inogen Inc
- Price
- $173.67-4.59%
- $6.43+0.31%
- Market cap
- $12.44B
- $174.1M
- 1M return
- +6.26%
- +1.42%
- 1Y return
- -5.33%
- -3.45%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2001
- 2014
- News (4w)
- 3
- 10
- Recent ratings
- 25
- 11
Align Technology Inc.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Latest ALGN
- Align Technology Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Align Technology Announces Board Leadership Transition. C. Raymond Larkin, Jr. to Retire as Chairman and Kevin Conroy to be Appointed Chairman Effective July 1, 2026
- Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research
- SEC Form SD filed by Align Technology Inc.
- Director Vitalone Britt J. converted options into 1,443 shares (SEC Form 4)
- Director Siegel Susan E converted options into 1,745 shares, increasing direct ownership by 19% to 10,723 units (SEC Form 4)
- Director Saia Andrea Lynn converted options into 1,745 shares, increasing direct ownership by 11% to 17,318 units (SEC Form 4)
- Director Poul Mojdeh converted options into 1,745 shares, increasing direct ownership by 97% to 3,553 units (SEC Form 4)
- Director Myong Anne converted options into 1,745 shares, increasing direct ownership by 22% to 9,830 units (SEC Form 4)
- Director Larkin C Raymond Jr converted options into 2,326 shares, increasing direct ownership by 9% to 27,454 units (SEC Form 4)
Latest INGN
- SEC Form S-8 filed by Inogen Inc
- Director Sahney Mira Kirti was granted 28,081 shares, increasing direct ownership by 71% to 67,805 units (SEC Form 4)
- Director Jamali Vafa was granted 28,081 shares, increasing direct ownership by 187% to 43,081 units (SEC Form 4)
- Director Boehnlein Glenn S was granted 28,081 shares, increasing direct ownership by 37% to 104,966 units (SEC Form 4)
- Director Rider Heather D. was granted 28,081 shares, increasing direct ownership by 32% to 116,282 units (SEC Form 4)
- Director Mora Elizabeth was granted 28,081 shares, increasing direct ownership by 35% to 107,261 units (SEC Form 4)
- Director Ladone Mary Kay was granted 28,081 shares, increasing direct ownership by 37% to 104,966 units (SEC Form 4)
- Director King Kevin M was granted 28,081 shares, increasing direct ownership by 37% to 104,966 units (SEC Form 4)
- New insider Jamali Vafa claimed ownership of 15,000 shares (SEC Form 3)
- EVP Entrprs Enblmnt, Ch HR Off Yi Boyer Jennifer M sold $70,313 worth of shares (10,770 units at $6.53) as part of a pre-agreed trading plan, decreasing direct ownership by 40% to 15,977 units (SEC Form 4)